CAS RN: 173999-19-4
5-Bromo-N-methylpyridine-3-sulfonamide
Product Availability
Choose a grade to view its available package options.
1 package records 0 with current stock 1 grade group
Grade
96% (1)
In stock only
Batch No. Package Availability Lead Time Inquiry
Batchno.20250813
100mg
Out of stock
8-10 business days Inquiry
GET A QUOTE
This product has historical factory records. Recorded pack sizes and purity can be used as a supply reference, while project-specific availability is confirmed by inquiry.
Pack sizes on record: 1g
Available purity: ≥96%
Inventory rows with stock: 0
Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 173999-19-4
Pack Size
Recorded Purity
Available Qty
Ship From
Inquiry
1g
≥96%
0
Out of Stock
Shenzhen
Inquiry
173999-19-4 / 5-bromo-N-methylpyridine-3-sulfonamide
Standard CAS: 173999-19-4
Multi CAS: No
Basic Information
copy
CAS
173999-19-4 copy
Multi CAS
No copy
Molecular Formula
C6H7BrN2O2S copy
Molecular Weight
251.100000 copy
Exact Mass
249.941160 copy
SMILES
CNS(=O)(=O)C1=CC(=CN=C1)Br copy
InChI
InChI=1S/C6H7BrN2O2S/c1-8-12(10,11)6-2-5(7)3-9-4-6/h2-4,8H,1H3 copy
InChIKey
SNFZSCOGEYEYJG-UHFFFAOYSA-N copy
Computed Properties
copy
Structural Parameters
Heavy atom count
12 copy
Aromatic heavy atom count
6 copy
Fraction Csp3
0.17 copy
Rotatable bonds
2 copy
H-bond acceptors
3 copy
H-bond donors
1 copy
Molar refractivity
48.18 copy
TPSA
59.06 copy
LogP / Solubility
WLOGP
0.75 copy
MLOGP
0.67 copy
XLogP3
0.5 copy
Consensus LogP
0.64 copy
Log S (ESOL)
-2.11 copy
Class (ESOL)
Moderately soluble copy
Log S (Ali)
-2.16 copy
Class (Ali)
Moderately soluble copy
Log S (SILICOS-IT)
-2.16 copy
Class (SILICOS-IT)
Moderately soluble copy
ADME
GI absorption
High copy
BBB permeant
Yes copy
P-gp substrate
No copy
CYP1A2 inhibitor
No copy
CYP2C19 inhibitor
No copy
CYP2C9 inhibitor
No copy
CYP2D6 inhibitor
No copy
CYP3A4 inhibitor
No copy
Log Kp (skin permeation)
-3.72 copy
Drug-likeness / Medicinal Chemistry
Lipinski
Yes copy
Ghose
No copy
Veber
Yes copy
Egan
Yes copy
Muegge
Yes copy
Bioavailability score
0.55 copy
Leadlikeness
Yes copy
Synthetic Accessibility
1.5 copy